CIK 0001743881 · Large accelerated filer
BridgeBio Pharma, Inc.
Sign in to watch- Ticker
- BBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (650) 391-9740
- Business address
- 3160 PORTER DR., SUITE 250, PALO ALTO, CA, 94304
- Former names
- BridgeBio Pharma LLC
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Planned sale Chief Accounting Officer sold 2,000 shares at $72.85 ($145,700)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 8-K Event Other events
- 4 Planned sale Chief Executive Officer sold 10,000 shares at an average $69.08 ($690,847)
- 8-K Event Other events
- 4 Planned sale Chief Executive Officer sold 44,980 shares at an average $82.86 ($3,727,251)
- 144 Insider Sale of Securities
- 4 Shares withheld for taxes President and CFO gave up 22,781 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Executive Officer gave up 36,237 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Accounting Officer gave up 4,714 shares (to pay taxes)
- 144 Insider Sale of Securities
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 144 Insider Sale of Securities
- 8-K Event Material agreement · Other events
- 424B7 Offering Prospectus
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
Page 1 of 42 · 834 filings